We really love the technology and its potential to make a
difference in creating a better world. We are very excited about what lies ahead for
PHILTER as one of our portfolio companies.
Nelson Cury
Managing Partner, Greenfield Global Opportunities Fund
I immediately recognized how the company will materially change the risk reduction paradigm to combat the harm done by secondhand smoke and harmful air from a variety of sources, a problem that has plagued societies since the turn of the last century.
David Paton
Former Head Global Open Innovations, BAT
Philter’s technology is foundational for a productive dialogue with Public Health
about protecting people and our environment from secondhand exposure to tobacco/cannabis smoke and aerosols. Technological solutions have not been
readily apparent until now. Through Philter’s technology, I can envision a future
without secondhand exposure.
Willie McKinney Ph.D., DABT
CEO, McKinney Regulatory Science Advisors, LLC and McKinney Specialty Labs
Secondhand operating room smoke and gas is a healthcare industry
risk that has never been fully addressed. Evacuation methods are
imprecise at best. Operating room teams (surgeons, anesthesiologists,
nurses, and technicians) spend the majority of their professional careers
exposed. PHILTER's innovative solutions have a tremendous opportunity
to improve the work safety at hospitals and outpatient surgery centers.
Dane M. Shipp, MD, OBGYN, FACOG, ABOG
The PHILTER leadership team is well seasoned. They have successfully managed the company through very difficult times, evolved their technology and made the proper adjustments for success. Their communication with investors and corporate governance is exemplary in the start-up world.
Lukasz Garbowski
Investment Director, Btomorrow Ventures
The Exhale Brief Newsletter
Weekly analysis of secondhand smoke & vape policy. What regulators and health officials are missing.